IPF Italian Observational Study (FIBRONET) in Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Boehringer Ingelheim
Related studies linked through entity extraction aliases.
Efficacy and Safety of Nintedanib Co-administered With Sildenafil in Idiopathic Pulmonary Fibrosis Patients With Advanced Lung Function Impairment
- Status
- COMPLETED
- Phase
- PHASE3
Observational Study to Evaluate Safety of Idarucizumab in Pediatric Patients
- Status
- WITHDRAWN
- Phase
- N/A
Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations
- Status
- COMPLETED
- Phase
- PHASE2
BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity Impairment
- Status
- COMPLETED
- Phase
- PHASE4
Anticoagulants Comparative Benefit-risk Ratio in Real Life
- Status
- COMPLETED
- Phase
- N/A
Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxin
- Status
- COMPLETED
- Phase
- PHASE1
Relative Bioavailability of BI 10773 Administered Twice Daily Compared BI 10773 Given Once Daily After Multiple Oral Doses in Healthy Male and Female Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Nintedanib Alone or in Combination With Capecitabine in Refractory Metastatic Colorectal Cancer [LUME-Colon 2]
- Status
- TERMINATED
- Phase
- PHASE2
Afatinib Monotherapy in Patients With ERBB-deregulated Metastatic Urothelial Tract Carcinoma After Failure of Platinum Based Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
STrategic Reperfusion in Elderly Patients Early After Myocardial Infarction
- Status
- COMPLETED
- Phase
- PHASE4
Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- PHASE1
Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis
- Status
- COMPLETED
- Phase
- PHASE2
Cambridge Brain Mets Trial 1
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Intravenous BI 836826 in Combination With Ibrutinib in Relapsed/Refractory CLL Patients Who Have Been Pre-treated With at Least One Prior Line of Systemic Therapy, and Who Are Eligible for Treatment With Ibrutinib
- Status
- COMPLETED
- Phase
- PHASE1
Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Linagliptin Compared With the Free Combination of Empagliflozin Tablet and Linagliptin Tablet in Healthy Male and Female Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Ph1 Volasertib Plus Romidepsin in R/R PTCL and CTCL
- Status
- WITHDRAWN
- Phase
- PHASE1
fMRI in Impulsivity
- Status
- COMPLETED
- Phase
- N/A